Share this article on:

Athletic Performance and Vitamin D

CANNELL, JOHN J.1; HOLLIS, BRUCE W.2; SORENSON, MARC B.3; TAFT, TIMOTHY N.4; ANDERSON, JOHN J. B.5

Medicine & Science in Sports & Exercise: May 2009 - Volume 41 - Issue 5 - p 1102-1110
doi: 10.1249/MSS.0b013e3181930c2b
Applied Sciences

Purpose: Activated vitamin D (calcitriol) is a pluripotent pleiotropic secosteroid hormone. As a steroid hormone, which regulates more than 1000 vitamin D-responsive human genes, calcitriol may influence athletic performance. Recent research indicates that intracellular calcitriol levels in numerous human tissues, including nerve and muscle tissue, are increased when inputs of its substrate, the prehormone vitamin D, are increased.

Methods: We reviewed the world's literature for evidence that vitamin D affects physical and athletic performance.

Results: Numerous studies, particularly in the German literature in the 1950s, show vitamin D-producing ultraviolet light improves athletic performance. Furthermore, a consistent literature indicates physical and athletic performance is seasonal; it peaks when 25-hydroxy-vitamin D [25(OH)D] levels peak, declines as they decline, and reaches its nadir when 25(OH)D levels are at their lowest. Vitamin D also increases the size and number of Type II (fast twitch) muscle fibers. Most cross-sectional studies show that 25(OH)D levels are directly associated with musculoskeletal performance in older individuals. Most randomized controlled trials, again mostly in older individuals, show that vitamin D improves physical performance.

Conclusions: Vitamin D may improve athletic performance in vitamin D-deficient athletes. Peak athletic performance may occur when 25(OH)D levels approach those obtained by natural, full-body, summer sun exposure, which is at least 50 ng·mL1. Such 25(OH)D levels may also protect the athlete from several acute and chronic medical conditions.

1Atascadero State Hospital, Atascadero, CA; 2Departments of Biochemistry and Molecular Biology, Medical University of South Carolina, Charleston, SC; 3sunlightandhealth.org, Saint George, UT; 4Departments of Orthopedics and Sports Medicine, University of North Carolina, Chapel Hill, NC; and 5Departments of Public Health and Nutrition, University of North Carolina, Chapel Hill, NC

Address for correspondence: John J. Cannell, M.D., Atascadero State Hospital, 10333 El Camino Real, Atascadero, CA 93422; E-mail: jcannell@dmhash.state.ca.us.

Submitted for publication August 2008.

Accepted for publication October 2008.

Vitamin D is not a vitamin in the usual sense of the word (12,32). That is, most natural human diets contain little vitamin D-unless those diets include much wild-caught fatty fish. Furthermore, activated vitamin D is a secosteroid hormone, not a cofactor in an enzymatic reaction or an antioxidant like most other vitamins. Moreover, the vitamin D steroid hormone system traditionally began in the skin, not in the mouth. Cutaneous production from incidental ultraviolet B (UVB) radiation in sunlight-not dietary intake-is the principal source of circulating human vitamin D stores (12,32).

Factors that affect cutaneous vitamin D production include latitude, season of the year, time of day, melanin content of the skin, use of sunblock, age, and the extent of clothing covering the body (12,32). When the sun is low on the horizon, atmospheric ozone, water vapor, and particulate air pollution all retard UVB penetration to the earth's surface. Thus, vitamin D-producing UVB radiation is effectively absent early and late in the day and for entire months during the winter at latitudes above 35°, causing the distinct seasonality of 25-hydroxy-vitamin D [25(OH)D] levels (Fig. 1).

FIGURE 1

FIGURE 1

Because cutaneous vitamin D production is absent or is drastically reduced during winter months, athletes who do not supplement or expose themselves to artificial UVB radiation have to rely on diet and summer vitamin D stores. The lack of significant amounts of vitamin D in most adult diets (even in diets containing fortified milk), ongoing catabolism of body stores, and declining UVB radiation as the autumn progresses cause serum 25(OH)D to precipitously decline in the fall and reach its nadir in the winter. Therefore, athletes competing in the northern half of the United States-and all of Canada and Europe-are at increased risk for vitamin D deficiency, especially during the late autumn and winter.

Like all humans, athletes at any latitude who practice and compete indoors while avoiding sun exposure are at risk any time of the year (12,32). Even those residing at sunny lower latitudes are at risk for deficiency if they consciously avoid the sun or properly use sunblock. For example, a surprisingly high incidence of vitamin D deficiency exists in Miami, despite its sunny weather and subtropical latitude (45).

Dark-skinned athletes face additional problems. Because cutaneous melanin acts as an effective and ever-present sunscreen, athletes with high concentrations of melanin in their skin need up to 10 times longer UVB exposure times to generate the same 25(OH)D stores than do fair-skinned ones (12,32). Therefore, indoor and dark-skinned athletes, athletes who live at more poleward latitudes, wear extensive clothing, regularly use sunblock, or consciously avoid the sun, are all at risk for vitamin D deficiency.

In the last 10 yr, it has become clear that the secosteroid hormone, 1,25-dihydroxy-vitamin D (calcitriol), is not exclusively produced by the kidneys, although the kidney fulfills the endocrine function of vitamin D by secreting calcitriol into serum to maintain the calcium economy. Locally produced and intracellularly regulated calcitriol-independent of serum calcitriol-directly affects numerous cells and tissues, fulfilling vitamin D's multiple autocrine functions (46). Like all steroid hormones, calcitriol acts as a molecular switch to signal genetic transcription. More than 1000 human genes are direct targets of calcitriol (65). Organs involved in athletic endeavors, with evidence of intracellular autocrine manufacture and regulation of calcitriol, include the heart, lungs, adrenal medulla, neurons, muscle, pituitary, bone, and brain (17). A wide variety of brain and nerve cells produce and regulate intracellular calcitriol in an independent autocrine manner, including the balance centers of the cerebellum (19). For a review of vitamin D's genomic and more rapid nongenomic effects on muscle, see Pfeifer et al. (54).

Back to Top | Article Outline

VITAMIN D DEFICIENCY

Holick (32), writing in the New England Journal of Medicine, recently warned that the number of diseases now associated with vitamin D deficiency-including many that afflict athletes-is growing. Very recently, Melamed et al. (50), using population data, found that total mortality was 26% higher in those with the lowest 25(OH)D levels compared with the highest. A meta-analysis of 18 randomized controlled trials found that supplemental vitamin D significantly reduced total mortality, that is, it prolongs life (2). The definition of vitamin D deficiency is changing almost yearly as research shows the low end of ideal 25(OH)D ranges is much higher than we thought only a few years ago (28,34). For example, very recent evidence indicates ideal levels may be above 50 ng·mL1 (27,33).

The parent compound (cholecalciferol) does not begin to be routinely stored in fat and muscle tissue for future use until 25(OH)D levels reach 40-50 ng·mL1 (27,33). At lower levels, the initial 25-hydroxylation in the liver usually follows first-order mass action kinetics, and the reaction is not saturable. That is, at levels below 40-50 ng·mL1, the body diverts most or all of the ingested or sun-derived vitamin D to immediate metabolic needs, signifying chronic substrate starvation.

At modern man's unnatural and abnormally low 25(OH)D levels-because of avoidance of sunlight-adequate cellular levels of calcitriol directly depend on the availability of adequate serum substrate [25(OH)D], which in turn, depends on vitamin D input; both reactions follow first-order mass action kinetics (67). Only when 25(OH)D levels reach 50 ng·mL1-and few people have such levels-that the initial hydroxylation in the liver reliably switches from first-order to zero-order kinetics (27,33). Thus, at 25(OH)D levels lower than 50 ng·mL1, tissue levels of the secosteroid, calcitriol, directly depend on the amount of vitamin D made in the skin or put in the mouth.

Although it seems improbable that many athletes-especially young ones consuming a good diet-could be vitamin D-deficient, recent evidence suggests many are. Large cross-sectional studies found that vitamin D deficiency is common in otherwise apparently healthy adult populations, and one must assume some of these adults participate in athletics (13,32,40,47,73). A surprisingly high number of otherwise healthy adolescents are also vitamin D-deficient (24,47). Likewise, the mean vitamin D intake in adolescents and young adults in the United States (from milk, other fortified foods, fish, and supplements combined) is 200-300 IU·d1 (73), an intake too low to have significant effects on 25(OH)D levels (67,68). Very recently, Gordon and her colleagues at Boston Children's Hospital found that 40% of 365 healthy infants and toddlers had 25(OH)D levels less than 30 ng·mL1, and it appears from extrapolating their data that more than 85% had levels below 40 ng·mL1 (25). The above studies indicate that few modern humans living in temperate latitudes-of any age-now achieve levels of 50 ng·mL1.

Back to Top | Article Outline

VITAMIN D DEFICIENCY AMONG ATHLETES

As Willis et al. (72) recently warned us, a surprisingly high percentage of athletes, especially indoor athletes, are probably vitamin D-deficient. For example, 77% of German gymnasts had 25(OH)D levels below 35 ng·mL1 and 37% had levels below 10 ng·mL1, which are in the osteomalacic range (data extrapolated from graph) (3). Forty-five percent of these gymnasts had hypocalcemia on at least one measurement, and several had undetectable 25(OH)D levels together with hypocalcaemia, which may lead to grand mal seizures. Quite surprisingly, the author did not suggest that these severely deficient gymnasts were unable to practice, although bony abnormalities were common. More recently, Lovell (48) found 15 of 18 elite gymnasts had levels below 30 ng·mL1 and 6 had levels below 20 ng·mL1.

A study of young Finnish female athletes (gymnasts and runners) found that athletes did not differ from nonathletes in either vitamin D intake or serum 25(OH)D levels, and both were more likely than not to be vitamin D-deficient (44). Sixty-seven percent of the young women had levels below 15 ng·mL1 during winter. Mean levels increased to 25 ng·mL1 at the end of a particularly sunny summer but fell to 16 ng·mL1 at the end of the yearlong study. A total of 400 IU of vitamin D daily (the equivalent of four glasses of American milk daily) for 3 months did not prevent these deficiencies. More recently, seven French cyclists training 16 h·wk1 had mean 25(OH)D levels of 32 ng·mL1, surprisingly low for a sport where sun exposure is common (49). No attempt was made to associate athletic performance with 25(OH)D levels in these four studies-or any study that we could locate.

Back to Top | Article Outline

ULTRAVIOLET IRRADIATION AND ATHLETIC PERFORMANCE

In 1938, Russian authors (26) reported that a course of ultraviolet irradiation improved speed in the 100-m dash in four students compared with matched controls, both groups undergoing daily physical training. Mean times improved 1.7% in the nonirradiated controls undergoing training but 7.4% in irradiated students undergoing identical training.

Indeed, in reading the early German literature, it seems the athletic benefits of UV radiation were widely known by the 1930s, at least in Germany (51):

"It is a well-known fact that physical performance can be increased through ultra-violet irradiation. In 1927, a heated argument arose after the decision by the German Swimmers' Association to use the sunlamp, as an artificial aid, as it may constitute an athletic unfairness, doping, so to speak." (p. 17).

In 1944, German investigators irradiated 32 medical students, twice a week for 6 wk, finding irradiated students showed a 13% improvement in performance on a bike ergometer, whereas the performance of the control students was unchanged (42). In 1945, Allen and Cureton (1) measured cardiovascular fitness and muscular endurance for 10 wk in 11 irradiated male Illinois college students, comparing them with 10 matched unirradiated controls, both groups undergoing similar physical training. The treatment group achieved a 19.2% standard score gain in cardiovascular fitness compared with a 1.5% improvement in the control students.

Several years later, Spellerberg (61) reported on the effects of an extensive program of irradiation of athletes training at the Sports College of Cologne-including many elite athletes-with a "central sun lamp." They reported a "convincing effect" on athletic performance and a significant reduction in chronic pain due to sports injuries. Improved athletic performance with irradiation was so convincing that Spellerberg notified the "National German and International Olympic Committee" (p. 570).

In 1952, Ronge (55) exposed 120 German schoolchildren to overhead UV lights for 9 months of the year. He installed the lights in classrooms and compared the treated children with 120 nonirradiated control children on a series of cardiovascular fitness tests on a bike ergometer (Fig. 2). He found that nonirradiated children showed a distinct seasonality in fitness and a 56% greater fitness in the irradiated compared with the nonirradiated control children in the early spring. He gave 30 children in the control classrooms 250,000 IU of vitamin D as a single dose in February and found that their cardiovascular performance improved dramatically, approaching the irradiated group 1 month later. Ronge seems to be the first to conclude "…the production of vitamin D (or of a related steroid) explains the success of UV-radiation with regards to physical performance…" (p. 565).

FIGURE 2

FIGURE 2

In 1954, researchers at the Max-Planck-Institute for Physiology (43) found that ultraviolet light in the vitamin D-producing UVB range was the most effective wavelength in consistently reducing resting pulse, lowering the basal metabolic rate, and increasing work performance on a bike ergometer. Two years later, Hettinger and Seidl (30) reported that UV radiation induced improvements in forearm muscle strength or performance on a bike ergometer in six of seven subjects.

In 1956, Sigmund (59) studied reaction times during the autumn in a series of controlled experiments on 16 children and an unspecified number of adults (Fig. 3). UV radiation improved choice reaction time by 17% in treated subjects, although it worsened in controls as the autumn progressed. In the late 1960s, American researchers found that even a single dose of ultraviolet irradiation tended to improve the strength, speed, and endurance of college women (14,56,57).

FIGURE 3-Effec

FIGURE 3-Effec

Back to Top | Article Outline

SEASONALITY OF PHYSICAL FITNESS

In active people, 25(OH)D levels are highly seasonal (Fig. 1). If vitamin D affected athletic performance, then measurements of physical performance should peak in the late summer, when 25(OH)D levels peak, start to decline in early autumn, as 25(OH)D levels fall, and reach their nadir in late winter, when 25(OH)D levels reach their nadir. Conversely, such seasonal changes in physical fitness could be due to seasonal changes in time spent exercising.

However, Hettinger and Muller (29) controlled for time spent exercising and found a distinct seasonal variation in the trainability of musculature (defined as percent strength increase divided by average strength increase, thus allowing small increases in trainability to be detected) by studying wrist flexor strength in subjects undergoing daily training. In seven subjects undergoing daily training for 7-10 consecutive months, they found highly significant seasonal differences in trainability with peak trainability during the late summer, a sharp autumn decline, and nadirs in the winter (Fig. 4).

FIGURE 4-Ave

FIGURE 4-Ave

A study of Polish pilots and crew found that physical fitness and tolerance to hypoxia were highest in the late summer with an unexplained sharp decline starting in September (39). Cumulative work ability among 1835 mainly sedentary Norwegian men during maximal bicycle exercise tests showed an August peak, wintertime nadir, and a sharp decline starting in the autumn (18).

Koch and Raschka (37) reviewed mostly German literature on the seasonality of physical performance, commenting on early studies indicating that strength and maximal oxygen uptake peak in the late summer. The authors then attempted to control for seasonal variations in the time spent exercising by instituting a controlled yearlong training regimen for a 36-yr-old male, beginning in December. The relative increase in the maximum number of press-ups peaked in late summer followed by a rapid decline in the fall, and a nadir in the winter, despite continued training. They speculated that seasonal variations in an unidentified hormone best explained their results.

Ten elite runners from the Swedish national track and field team, in year-round training, displayed maximal oxygen uptake during the summer months (63). Others found significant summer/winter differences in heart rate variability in 120 healthy male Israeli mechanical engineers (38). Lower heart rate variability, which is associated with cardiac pathology, occurred during the winter. Ten healthy male Japanese students showed a significant seasonal variation in CO2 sensitivity with unexplained improvements in late summer, a rapid decline beginning in September, and a nadir in January (31).

Back to Top | Article Outline

VITAMIN D'S EFFECT ON MUSCLE

Birge and Haddad (5) found that exogenous 25(OH)D affected ne novo protein synthesis in muscle, concluding it acts directly on muscle to increase protein synthesis. Administration of vitamin D to deficient rats leads to improved muscle protein anabolism and an increase in muscle mass, weight gain, and a decrease in the rate of myofibrillar protein degradation (70).

Three human muscle biopsy studies confirmed the findings in animals. Biopsies on 12 vitamin D-deficient patients, before and after vitamin D treatment, found atrophy of Type II muscle fibers before treatment and significant improvement after treatment (74). Muscle biopsies on 11 older patients with osteoporosis, before and after administration of a vitamin D analog together with 1000 mg of calcium for 3-6 months, showed significant increases in both the percentage and area of Type II fibers, despite the lack of any physical training (60). Two years of treatment with even a low dose of vitamin D-1000 IU of ergocalciferol per day-significantly increased muscle strength, doubled the mean diameter, and tripled the percentage of Type II muscle fibers in the functional limbs of 48 severely vitamin D-deficient elderly hemiplegic women (58). The placebo control group suffered declines in muscle strength and in the size and percentage of Type II muscle fibers.

Back to Top | Article Outline

SERUM 25(OH)D AND NEUROMUSCULAR FUNCTION

Several cross-sectional studies (6,7,22,35,36,53,64,69,75) have assessed associations between 25(OH)D and various parameters of neuromuscular performance, finding direct associations between 25(OH)D levels and some measure of physical performance. Many of the studies corrected for factors known to be inversely associated with 25(OH)D levels, such as age, BMI, and serum PTH, so colinearity may be masking stronger associations. Correlations were more frequent and strongest for reaction time, balance, and timed tests of physical performance.

Three additional cross-sectional community studies (9,21,71) found direct associations between 25(OH)D and physical performance with the most dramatic differences noted between 10 and 30 ng·mL1. They also found evidence of a 25(OH)D threshold around 40-50 ng·mL1, above which further improvements in neuromuscular performance were not seen. The largest cross-sectional community study (9) found a linear correlation and suggestion of a U-shaped curve (Fig. 5) with performance on time to stand tests peaking at 50 ng·mL1. However, some longitudinal studies have shown associations (69,71), and others have not (4,20,66), raising the possibility of reverse causation.

FIGURE 5

FIGURE 5

Back to Top | Article Outline

INTERVENTIONAL TRIALS OF VITAMIN D AND NEUROMUSCULAR PERFORMANCE

Several randomized controlled trials (6,16,23,52,58) in older adults found that vitamin D improves various parameters of neuromuscular functioning, including balance, muscle strength, and reaction time, whereas others found no effect (10,36,41). A case-control study of younger subjects (22) showed dramatic improvements in 55 severely vitamin D-deficient younger subjects. Comparisons between studies are difficult because the authors used a wide variety of vitamin D preparations and doses, and subjects began treatment with widely varying baseline 25(OH)D levels.

Another test of the theory are interventional studies in reducing falls, assuming falls are failures of athletic performance. Bischoff-Ferrari et al. (8) recently reviewed that literature and concluded that vitamin D, even in relatively low doses (800 IU·d1), reduces falls in the elderly.

Back to Top | Article Outline

DISCUSSION

We reviewed five independent lines of evidence, all of which converge to support the hypothesis that vitamin D may improve athletic performance. Ultraviolet B radiation seems to improve various measurements of athletic performance, but data are largely descriptive and adequate randomized controlled trials are lacking. Several studies showed performance improves with vitamin D-producing UVB light but not UVA. Another unidentified component of UVB radiation, not connected to vitamin D, may explain these findings. However, other than the production of the precursor for the steroid hormone, activated vitamin D, we are not aware of any other biological effects of UVB radiation that could do so.

Associations between peak physical performance and summer season are quite significant, even when physical conditioning was constant. However, this may be secondary to reverse causation. That is, improved physical performance in the summer-and thus high 25(OH)D levels-might be secondary to additional outdoor physical activity in the warmer weather. However, if this is true and using the same logic, physical performance should not begin to decline until late autumn, because-at most temperate latitudes-early fall weather is ideal for outdoor athletics. Besides a consistent positive association of late summer season with peak athletic performance, the above studies found an abrupt, and unexplained, reduction in physical performance beginning when 25(OH)D levels decline (early autumn). Another explanation, that is, testosterone peaks in the summer, fails; the two largest studies of such seasonality show testosterone levels peak in December (15,62).

Studies of muscle biopsies of severely vitamin D-deficient patients, before and after treatment, indicate that vitamin D increases the number and diameter of fast, Type II muscle fibers. Several large community-based cross-sectional studies of neuromuscular functioning and serum 25(OH)D found positive associations, but prospective cohort studies are conflicting, raising the possibility of reverse causation. Most, but not all, placebo-controlled interventional studies in older adults found that vitamin D improves various parameters of neuromuscular functioning.

Few athletes live and train in a sun-rich environment, thus few have "natural" 25(OH)D levels, with the exception of equatorial athletes, such as the runners of Kenya. Another possible exception was the 1968 Summer Olympics in Mexico City, where athletes had to arrive early to acclimatize to the 7400-ft altitude. Because UVB penetration of the atmosphere is higher at high altitudes, because Mexico City is relatively close to the equator, and because of the summer season, ambient UVB irradiation from sunlight would have been intense during the 1968 summer games and should have rapidly increased 25(OH)D levels of any athlete acclimatizing outdoors.

Many new world records were set that summer, and the Americans, perhaps unexpectedly, won more gold and total medals than either the Russians or East Germans. Although most experts attribute the impressive number of world records to decreased ambient air pressure, vitamin D may also have contributed. For example, the Americans dominated in outdoor sports, winning 42 of their 45 gold medals in outdoor sports, whereas the Russians won most their gold medals (18 of 29) in indoor sports. Both the number of new world records, almost entirely in outdoor sports, and the percentage improvement in outdoor world records, for example, Bob Beamon added 21 inches to the long jump (Fig. 6), are consistent with the theory that vitamin D improves athletic performance.

FIGURE 6

FIGURE 6

Back to Top | Article Outline

CONCLUSIONS

Extant evidence suggests that adequate treatment of vitamin D-deficient athletes may improve their athletic performance. If such a treatment effect exists, the largest improvements in performance will probably occur in those with the lowest levels; that is, a significant improvement in athletic performance may occur when levels increase from 15 to 30 ng·mL1, but less improvement will occur when levels increase from 30 to 50 ng·mL1. However, both the theory and any existence of any ideal 25(OH)D levels needed for peak athletic performance need confirmations by properly conducted interventional trials. If an effect exists, what is its magnitude? Which athletic performance variables (reaction time, muscle strength, balance, coordination, or endurance) improve the most? What is the optimal 25(OH)D level for peak athletic performance? Do higher levels impair it?

Only direct interventional studies in vitamin D-deficient athletes will answer the athletic performance questions. A double-blind, placebo-controlled, multiple-dose crossover study with long washout periods using variable but relatively high physiological doses, such as 2000, 4000, and 6000 IU of vitamin D·d1, combined with periodic 25(OH)D levels, might answer the question of whether peak performance levels exist for any particular serum 25(OH)D. Alternatively, vitamin D-deficient athletes could ingest doses calculated to increase baseline 25(OH)D levels to approximately 50 ng·mL1, the levels Bischoff-Ferrari et al. (9) found to be associated with peak neuromuscular performance. However, given the growing medical literature on the dangers of vitamin D deficiency (32), ethical concerns may arise in identifying, but not treating, a vitamin D-deficient control group.

Because activated vitamin D is a secosteroid hormone, questions may arise if use of its precursor, vitamin D, constitutes an unfair advantage, "doping, so to speak," as the Germans noted in 1940 (51). However, unlike testosterone or growth hormone, vitamin D deficiency is probably common among athletes. Furthermore, untreated vitamin D deficiency is associated with numerous serious illnesses (32) and is a risk factor for early death (50). Withholding vitamin D in vitamin D-deficient athletes seems to violate most rules of modern medical ethics and may expose the sports medicine physician to needless future liability (12).

Although science may or may not find performance-enhancing effects of vitamin D in the future, good medical practice in the present always supersedes performance-enhancing theories awaiting future research. Vitamin D deficiency may be quite common in athletes. Stress fractures, chronic musculoskeletal pain, viral respiratory tract infections, and several chronic diseases are associated with vitamin D deficiency (11,12,32,72). Those caring for athletes have a responsibility to promptly diagnose and adequately treat vitamin D deficiency. Adequate treatment requires thousands, not hundreds, of IU of vitamin D daily, doses that may make many sports physicians uncomfortable (12).

J. J. C. is a consultant for DiaSorin Corporation, which makes vitamin D testing equipment, and heads the nonprofit educational organization, the Vitamin D Council. B. W. H. is a consultant for DiaSorin Corporation.

Disclosure of funding: none.

The results of the present review do not constitute endorsement by ACSM.

Back to Top | Article Outline

REFERENCES

1. Allen R, Cureton T. Effects of ultraviolet radiation on physical fitness. Arch Phys Med. 1945;10:641-4.
2. Autier P, Gandini S. Vitamin D supplementation and total mortality: a meta-analysis of randomized controlled trials. Arch Intern Med. 2007;167(16):1730-7.
3. Bannert N, Starke I, Mohnike K, Frohner G. [Parameters of mineral metabolism in children and adolescents in athletic training.] Kinderarztl Prax. 1991;59(5):153-6. [Article in German].
4. Bartali B, Frongillo EA, Guralnik JM, et al. Serum micronutrient concentrations and decline in physical function among older persons. JAMA. 2008;299(3):308-15.
5. Birge SJ, Haddad JG. 25-Hydroxycholecalciferol stimulation of muscle metabolism. JClin Invest. 1975;56(5):1100-7.
6. Bischoff HA, Stahelin HB, Dick W, et al. Effects of vitamin D and calcium supplementation on falls: a randomized controlled trial. J Bone Miner Res. 2003;18(2):343-51.
7. Bischoff HA, Stahelin HB, Urscheler N, et al. Muscle strength in the elderly: its relation to vitamin D metabolites. Arch Phys Med Rehabil. 1999;80(1):54-8.
8. Bischoff-Ferrari HA, Dawson-Hughes B, Willett WC, et al. Effect of vitamin D on falls: a meta-analysis. JAMA. 2004;291(16):1999-2006.
9. Bischoff-Ferrari HA, Dietrich T, Orav EJ, et al. Higher 25-hydroxyvitamin D concentrations are associated with better lower-extremity function in both active and inactive persons aged > or =60 y. Am J Clin Nutr. 2004;80(3):752-8.
10. Brunner RL, Cochrane B, Jackson RD, et al. Calcium, vitamin D supplementation, and physical function in the Women's Health Initiative. J Am Diet Assoc. 2008;108(9):1472-9.
11. Cannell JJ, Hollis BW. Use of vitamin D in clinical practice. Altern Med Rev. 2008;13(1):6-20.
12. Cannell JJ, Hollis BW, Zasloff M, Heaney RP. Diagnosis and treatment of vitamin D deficiency. Expert Opin Pharmacother. 2008;9:107-18.
13. Chapuy MC, Preziosi P, Maamer M, et al. Prevalence of vitamin D insufficiency in an adult normal population. Osteoporos Int. 1997;7(5):439-43.
14. Cheatum BA. Effects of a single biodose of ultraviolet radiation upon the speed of college women. Res Q. 1968;39(3):482-5.
15. Dabbs JM Jr. Age and seasonal variation in serum testosterone concentration among men. Chronobiol Int. 1990;7(3):245-9.
16. Dhesi JK, Jackson SH, Bearne LM, et al. Vitamin D supplementation improves neuromuscular function in older people who fall. Age Ageing. 2004;33(6):589-95.
17. Dusso AS, Brown AJ, Slatopolsky E. Vitamin D. Am J Physiol Renal Physiol. 2005;289(1):F8-28.
18. Erikssen J, Rodahl K. Seasonal variation in work performance and heart rate response to exercise. A study of 1,835 middle-aged men. Eur J Appl Physiol Occup Physiol. 1979;42(2):133-40.
19. Eyles DW, Smith S, Kinobe R, Hewison M, McGrath JJ. Distribution of the vitamin D receptor and 1 alpha-hydroxylase in human brain. J Chem Neuroanat. 2005;29(1):21-30.
20. Faulkner KA, Cauley JA, Zmuda JM, et al. Higher 1,25-dihydroxyvitamin D3 concentrations associated with lower fall rates in older community-dwelling women. Osteoporos Int. 2006;17(9):1318-28.
21. Gerdhem P, Ringsberg KA, Obrant KJ, Akesson K. Association between 25-hydroxy vitamin D levels, physical activity, muscle strength and fractures in the prospective population-based OPRA Study of Elderly Women. Osteoporos Int. 2005;16(11):1425-31.
22. Glerup H, Mikkelsen K, Poulsen L, et al. Hypovitaminosis D myopathy without biochemical signs of osteomalacic bone involvement. Calcif Tissue Int. 2000;66(6):419-24.
23. Gloth FM 3rd, Smith CE, Hollis BW, Tobin JD. Functional improvement with vitamin D replenishment in a cohort of frail, vitamin D-deficient older people. J Am Geriatr Soc. 1995;43(11):1269-71.
24. Gordon CM, DePeter KC, Feldman HA, Grace E, Emans SJ. Prevalence of vitamin D deficiency among healthy adolescents. Arch Pediatr Adolesc Med. 2004;158(6):531-7.
25. Gordon CM, Feldman HA, Sinclair L, et al. Prevalence of vitamin D deficiency among healthy infants and toddlers. Arch Pediatr Adolesc Med. 2008;162(6):505-12.
26. Gorkin Z, Gorkin MJ, Teslenko NE. [The effect of ultraviolet irradiation upon training for 100m sprint.] Fiziol Zh USSR. 1938;25:695-701. [Article in Russian].
27. Heaney RP, Armas LA, Shary JR, Bell NH, Binkley N, Hollis BW. 25-Hydroxylation of vitamin D3: relation to circulating vitamin D3 under various input conditions. Am J Clin Nutr. 2008;87:1738-42.
28. Heaney RP. The vitamin D requirement in health and disease. J Steroid Biochem Mol Biol. 2005;97(1-2):13-9.
29. Hettinger T, Muller EA. [Seasonal course of trainability of musculature.] Int Z Angew Physiol. 1956;16(2):90-4. [Article in German].
30. Hettinger T, Seidl E. [Ultraviolet irradiation and trainability of musculature.] Int Z Angew Physiol. 1956;16(3):177-83. [Article in German].
31. Hiruta S, Ishida K, Miyamura M. Seasonal variations of ventilatory response to hypercapnia at rest. Jpn J Physiol. 1990;40(5):753-7.
32. Holick MF. Vitamin D deficiency. N Engl J Med. 2007;357:266-81.
33. Hollis BW, Wagner CL, Drezner MK, Binkley NC. Circulating vitamin D3 and 25-hydroxyvitamin D in humans: an important tool to define adequate nutritional vitamin D status. JSteroid Biochem Mol Biol. 2007;103:631-4.
34. Hollis BW. Circulating 25-hydroxyvitamin D levels indicative of vitamin D sufficiency: implications for establishing a new effective dietary intake recommendation for vitamin D. J Nutr. 2005;135(2):317-22.
35. Iannuzzi-Sucich M, Prestwood KM, Kenny AM. Prevalence of sarcopenia and predictors of skeletal muscle mass in healthy, older men and women. J Gerontol A Biol Sci Med Sci. 2002;57(12):M772-7.
36. Kenny AM, Biskup B, Robbins B, Marcella G, Burleson JA. Effects of vitamin D supplementation on strength, physical function, and health perception in older, community-dwelling men. J Am Geriatr Soc. 2003;51(12):1762-7.
37. Koch H, Raschka C. Circannual period of physical performance analysed by means of standard cosinor analysis: a case report. Rom J Physiol. 2000;37(1-4):51-8.
38. Kristal-Boneh E, Froom P, Harari G, Malik M, Ribak J. Summer-winter differences in 24 h variability of heart rate. J Cardiovasc Risk. 2000;7(2):141-6.
39. Kwarecki K, Golec L, Klossowski M, Zuzewicz K. Circannual rhythms of physical fitness and tolerance of hypoxic hypoxia. Acta Physiol Pol. 1981;32(6):629-36.
40. Lamberg-Allardt CJ, Outila TA, Karkkainen MU, Rita HJ, Valsta LM. Vitamin D deficiency and bone health in healthy adults in Finland: could this be a concern in other parts of Europe? J Bone Miner Res. 2001;16(11):2066-73.
41. Latham NK, Anderson CS, Lee A, et al. A randomized, controlled trial of quadriceps resistance exercise and vitamin D in frail older people: the Frailty Interventions Trial in Elderly Subjects (FITNESS). J Am Geriatr Soc. 2003;51(3):291-9.
42. Lehmann G, Mueller EA. [Ultraviolet irradiation and altitude fitness.] Luftfahrtmedizin. 1944;9:37-43. [Article in German].
43. Lehmann G. [Significance of certain wave lengths for increased efficacy of ultraviolet irradiation.] Strahlentherapie. 1954;95(3):447-53. [Article in German].
44. Lehtonen-Veromaa M, Mottonen T, Irjala K, et al. Vitamin D intake is low and hypovitaminosis D common in healthy 9- to 15-year-old Finnish girls. Eur J Clin Nutr. 1999;53(9):746-51.
45. Levis S, Gomez A, Jimenez C, et al. Vitamin d deficiency and seasonal variation in an adult South Florida population. J Clin Endocrinol Metab. 2005;90(3):1557-62.
46. Lips P. Vitamin D physiology. Prog Biophys Mol Biol. 2006;92(1):4-8.
47. Looker AC, Dawson-Hughes B, Calvo MS, Gunter EW, Sahyoun NR. Serum 25-hydroxyvitamin D status of adolescents and adults in two seasonal subpopulations from NHANES III. Bone. 2002;30(5):771-7.
48. Lovell G. Vitamin D status of females in an elite gymnastics program. Clin JSport Med. 2008;18(2):159-61.
49. Maïmoun L, Manetta J, Couret I, et al. The intensity level of physical exercise and the bone metabolism response. Int J Sports Med. 2006;27(2):105-11.
50. Melamed ML, Michos ED, Post W, Astor B. 25-Hydroxyvitamin D levels and the risk of mortality in the general population. Arch Intern Med. 2008;168(15):1629-37.
51. Parade GW, Otto H. [Effect of sunlamp on performance.] Zeitschrift fur Klinische Medizin. 1940;137:17-21. [Article in German].
52. Pfeifer M, Begerow B, Minne HW, Abrams C, Nachtigall D, Hansen C. Effects of a short-term vitamin D and calcium supplementation on body sway and secondary hyperparathyroidism in elderly women. J Bone Miner Res. 2000;15(6):1113-8.
53. Pfeifer M, Begerow B, Minne HW, et al. Vitamin D status, trunk muscle strength, body sway, falls, and fractures among 237 postmenopausal women with osteoporosifs. Exp Clin Endocrinol Diabetes. 2001;109(2):87-92.
54. Pfeifer M, Begerow B, Minne HW. Vitamin D and muscle function. Osteoporos Int. 2002;13(3):187-94.
55. Ronge HE. [Increase of physical effectiveness by systematic ultraviolet irradiation.] Strahlentherapie. 1952;88:563-6. [Article in German].
56. Rosentsweig J. The effect of a single suberythemic biodose of ultraviolet radiation upon the strength of college women. J Assoc Phys Ment Rehabil. 1967;21(4):131-3.
57. Rosentswieg J. The effect of a single suberythemic biodose of ultraviolet radiation upon the endurance of college women. J Sports Med Phys Fitness. 1969;9(2):104-6.
58. Sato Y, Iwamoto J, Kanoko T, Satoh K. Low-dose vitamin D prevents muscular atrophy and reduces falls and hip fractures in women after stroke: a randomized controlled trial. Cerebrovasc Dis. 2005;20(3):187-92.
59. Sigmund R. [Effect of ultraviolet rays on reaction time in man.] Strahlentherapie. 1956;101(4):623-9. [Article in German].
60. Sorensen OH, Lund B, Saltin B, et al. Myopathy in bone loss of ageing: improvement by treatment with 1 alpha-hydroxycholecalciferol and calcium. Clin Sci (Lond). 1979;56(2):157-61.
61. Spellerberg AE.[Increase of athletic effectiveness by systematic ultraviolet irradiation.] Strahlentherapie. 1952;88:567-70. [Article in German].
62. Svartberg J, Jorde R, Sundsfjord J, Bonaa KH, Barrett-Connor E. Seasonal variation of testosterone and waist to hip ratio in men:the Tromso study. J Clin Endocrinol Metab. 2003;88(7):3099-104.
63. Svedenhag J, Sjodin B. Physiological characteristics of elite malerunners in and off-season. Can J Appl Sport Sci. 1985;10(3):127-33.
64. Szulc P, Duboeuf F, Marchand F, Delmas PD. Hormonal and lifestyle determinants of appendicular skeletal muscle mass in men: the MINOS study. Am J Clin Nutr. 2004;80(2):496-503.
65. Tavera-Mendoza LE, White JH. Cell defenses and the sunshine vitamin. Sci Am. 2007;297(5):62-5, 68-70, 72.
66. Verreault R, Semba RD, Volpato S, Ferrucci L, Fried LP, Guralnik JM. Low serum vitamin d does not predict new disability or loss of muscle strength in older women. J Am Geriatr Soc. 2002;50(5):912-7.
67. Vieth R. The pharmacology of vitamin D, including fortification strategies. In: Feldman D, Pike JW, Glorieux FH, editors. Vitamin D. San Diego (CA): Elsevier; 2005. p. 995-1015.
68. Vieth R. Vitamin D supplementation, 25-hydroxyvitamin D concentrations, and safety. Am J Clin Nutr. 1999;69(5):842-56.
69. Visser M, Deeg DJ, Lips P; Longitudinal Aging Study Amsterdam. Low vitamin D and high parathyroid hormone levels as determinants of loss of muscle strength and muscle mass (sarcopenia): the Longitudinal Aging Study Amsterdam. J Clin Endocrinol Metab. 2003;88(12):5766-72.
70. Wassner SJ, Li JB, Sperduto A, Norman ME. Vitamin D deficiency, hypocalcemia, and increased skeletal muscle degradation in rats. J Clin Invest. 1983;72(1):102-12.
71. Wicherts IS, van Schoor NM, Boeke AJ, et al. Vitamin D status predicts physical performance and its decline in older persons. J Clin Endocrinol Metab. 2007;92(6):2058-65.
72. Willis KS, Peterson NJ, Larson-Meyer DE. Should we be concerned about the vitamin D status of athletes? Int JSport Nutr Exerc Metab. 2008;18:204-24.
73. Yetley EA. Assessing the vitamin D status of the US population. Am J Clin Nutr. 2008;88(2):558S-64S.
74. Young A, Edwards R, Jones D, Brenton D. Quadriceps muscle strength and fibre size during treatment of osteomalacia. In: Stokes IAF, editor. Mechanical Factors and the Skeleton. Vol. 12. London (England): John Libbey; 1981. p. 137-45.
75. Zamboni M, Zoico E, Tosoni P, et al. Relation between vitamin D, physical performance, and disability in elderly persons. J Gerontol A Biol Sci Med Sci. 2002;57(1):M7-11.
Keywords:

PHYSICAL PERFORMANCE; PEAK ATHLETIC PERFORMANCE; ACTIVATED VITAMIN D; CALCITRIOL; 1; 25-DIHYDROXY-VITAMIN D; 25(OH)D

©2009The American College of Sports Medicine